# Breast Cancer Diagnosis ‚Äî Machine Learning Project (CRISP-DM)

## üìå Project Overview
This project applies machine learning techniques to support **breast cancer diagnosis**, with a strong focus on **early detection**, **clinical reliability**, and **interpretability**.  
The work follows the **CRISP-DM methodology**, ensuring a structured, transparent, and medically aligned data science process.

The objective is to assist clinicians in distinguishing between **benign** and **malignant** tumors using quantitative features extracted from breast cancer datasets.

---

## üè• Business Objectives (BO)

- **BO1** ‚Äî Detect breast cancer as early as possible  
- **BO2** ‚Äî Improve diagnostic decision-making and reduce errors  
- **BO3** ‚Äî Reduce unnecessary tests, biopsies, and medical procedures  
- **BO4** ‚Äî Prioritize patients requiring urgent medical attention  

---

## üéØ Data Science Objectives (DSO)

- **DSO1** ‚Äî Maximize Recall (True Positive Rate) to avoid missing malignant cases  
- **DSO2** ‚Äî Minimize False Positives to reduce unnecessary medical interventions  
- **DSO3** ‚Äî Ensure fast, interpretable, and clinically actionable models  
- **DSO4** ‚Äî Achieve robust generalization across diverse tumor characteristics  

---

## üß™ Datasets

This project uses **two complementary breast cancer datasets**, which were **merged to improve robustness and generalization**.

### 1Ô∏è‚É£ Wisconsin Diagnostic Breast Cancer (WDBC)
- Features extracted from digitized images of breast mass fine needle aspirates
- Includes **mean**, **standard error**, and **worst-case** measurements
- Binary target variable:  
  - `0` ‚Üí Benign  
  - `1` ‚Üí Malignant  

### 2Ô∏è‚É£ Wisconsin Prognostic Breast Cancer (WPBC)
- Contains tumor-related features associated with disease progression
- Introduces additional variability in tumor morphology
- Used to enrich the dataset and improve generalization

### üîó Dataset Integration
- Common and compatible features between **WDBC** and **WPBC** were identified
- Datasets were **cleaned, aligned, and merged**
- The merged dataset improves:
  - tumor heterogeneity representation
  - robustness across patient profiles (**DSO4**)

---

## üîç Methodology ‚Äî CRISP-DM Phases

### Phase 1 ‚Äî Business Understanding
Clinical and diagnostic objectives were defined to ensure alignment between machine learning performance and real medical needs.

---

### Phase 2 ‚Äî Data Understanding
- Exploratory Data Analysis (EDA)
- Analysis of class distribution (benign vs malignant)
- Box plots for mean, standard error, and worst features
- Detection of variability, scale differences, and outliers
- Clinical interpretation of extreme values

---

### Phase 3 ‚Äî Data Preparation
- Harmonization of WDBC and WPBC features
- Handling of missing and inconsistent values
- Feature standardization
- **Principal Component Analysis (PCA)**:
  - Dimensionality reduction
  - Analysis of feature representation (cos¬≤)
  - Identification of dominant tumor characteristics
- Train/test split
- Retention of clinically meaningful outliers

---

### Phase 4 ‚Äî Modeling
The following models were trained and compared:

- Linear Regression (baseline)
- ElasticNet Logistic Regression
- Linear SVM (C tuned)
- RBF SVM (GRU-SVM Proxy)
- L1NN / L2NN (Manhattan / Euclidean k-NN)
- Random Forest
- MLP (500-500-500 with Early Stopping)

---

### Phase 5 ‚Äî Evaluation
- Accuracy, Recall (TPR), Selectivity (TNR), FPR, FNR
- Confusion matrices
- ROC curves and AUC comparison
- Model-to-DSO alignment analysis
- Clinical error analysis (false positives vs false negatives)

---

## üèÜ Model Recommendation (Summary)

- **Primary Screening Model:** MLP (Early Stopping) ‚Äî optimized for high Recall  
- **Interpretable Clinical Model:** ElasticNet Logistic Regression  
- **Robust Validation Model:** Random Forest  

A **hybrid decision-support strategy** is recommended rather than relying on a single model.

---

## üìä Key Visualizations
- Box plots (Mean / SE / Worst features)
- ROC curves for all evaluated models
- Confusion matrices
- PCA cos¬≤ heatmap (feature representation quality)
- LIME explanations for model interpretability

---

## üöÄ Deployment (Planned ‚Äî Not Implemented Yet)

> This section is intentionally left for future work.

Planned deployment considerations include:
- Model serialization
- API-based inference service
- Clinical decision-support integration
- Threshold calibration based on hospital policy
- Monitoring model performance and data drift

---

## ‚ö†Ô∏è Disclaimer
This project is for **educational and research purposes only**.  
It is **not a medical device** and should not be used for clinical diagnosis without proper validation and regulatory approval.

---

## üë• Team
**The Matrix-Makers**  
Data Science & Machine Learning Project Team

---

